Aprea Therapeutics, Inc. (APRE) Gross margin
Aprea Therapeutics, Inc. (APRE) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to APRESource: SEC XBRL filings · For reference only · Not investment advice
More APRE financial trends
APRE RevenueAPRE Net incomeAPRE Net marginAPRE Gross profitAPRE Operating incomeAPRE Operating marginAPRE Operating cash flowAPRE Free cash flowAPRE Capital expendituresAPRE Return on equityAPRE Stock buybacksAPRE Dividends paidAPRE Total assetsAPRE Total liabilitiesAPRE Shareholders’ equityAPRE overview →